News & Updates

Show Multimedia Only
Mirabegron a potentially safer alternative to solifenacin for paediatric OAB
Mirabegron a potentially safer alternative to solifenacin for paediatric OAB
28 Mar 2026 byJairia Dela Cruz

In the treatment of overactive bladder (OAB) in children, mirabegron demonstrates efficacy similar to that of solifenacin but has a better safety profile, according to a meta-analysis presented at the annual EAU Congress.

Mirabegron a potentially safer alternative to solifenacin for paediatric OAB
28 Mar 2026